The Role of Palmitic Acid in the Co-Toxicity of Bacterial Metabolites to Endothelial Cells

Vasc Health Risk Manag. 2023 Jul 4:19:399-409. doi: 10.2147/VHRM.S408897. eCollection 2023.

Abstract

Introduction: Metabolic endotoxemia most often results from obesity and is accompanied by an increase in the permeability of the intestinal epithelial barrier, allowing co-absorption of bacterial metabolites and diet-derived fatty acids into the bloodstream. A high-fat diet (HFD) leading to obesity is a significant extrinsic factor in developing vascular atherosclerosis. In this study, we evaluated the effects of palmitic acid (PA) as a representative of long-chain saturated fatty acids (LCSFA) commonly present in HFDs, along with endotoxin (LPS; lipopolysaccharide) and uremic toxin indoxyl sulfate (IS), on human vascular endothelial cells (HUVECs).

Methods: HUVECs viability was measured based on tetrazolium salt metabolism, and cell morphology was assessed with fluorescein-phalloidin staining of cells' actin cytoskeleton. The effects of simultaneous treatment of endothelial cells with PA, LPS, and IS on nitro-oxidative stress in vascular cells were evaluated quantitatively with fluorescent probes. The expression of vascular cell adhesion molecule VCAM-1, E-selectin, and occludin, an essential tight junction protein, in HUVECs treated with these metabolites was evaluated in Western blot.

Results: PA, combined with LPS and IS, did not influence HUVECs viability but induced stress on actin fibers and focal adhesion complexes. Moreover, PA combined with LPS significantly enhanced reactive oxygen species (ROS) production in HUVECs but decreased nitric oxide (NO) generation. PA also considerably increased the expression of VCAM-1 and E-selectin in HUVECs treated with LPS or IS but decreased occludin expression.

Conclusion: Palmitic acid enhances the toxic effect of metabolic endotoxemia on the vascular endothelium.

Keywords: endotoxin; high-fat diet; indoxyl sulfate; metabolic endotoxemia; palmitic acid.

MeSH terms

  • E-Selectin
  • Endothelium, Vascular
  • Endotoxemia* / metabolism
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Lipopolysaccharides / metabolism
  • Lipopolysaccharides / pharmacology
  • Obesity
  • Occludin / metabolism
  • Occludin / pharmacology
  • Palmitic Acid* / metabolism
  • Palmitic Acid* / toxicity
  • Vascular Cell Adhesion Molecule-1 / metabolism
  • Vascular Cell Adhesion Molecule-1 / pharmacology

Substances

  • Palmitic Acid
  • E-Selectin
  • Occludin
  • Lipopolysaccharides
  • Vascular Cell Adhesion Molecule-1

Grants and funding

The study was prepared under the project financed from the funds granted by the Ministry of Education and Science in Poland, in the “Regional Initiative of Excellence” program for the years 2019–2022, project number 016/RID/2018/19 (individual project number RID Z501.20.009).